Neurol. praxi. 2009;10(3):180-183

Adult-onset huntington disease phenocopies

MUDr. Martin Kucharík, MUDr. Jiří Klempíř, Ph.D, doc. MUDr. Jan Roth CSc
Neurologická klinika 1. LF UK a VFN, Praha

Huntington´s disease (HD) is a well-defined autosomal dominant neurodegenerative disease. It is caused by CAG repeat expansions in huntingtin

gene. There are a significant number of HD cases where this mutation was not found and such cases are named HD-like phenotype

(HDL) or HD phenocopies. The aim of our work is to review these HDL. We studied existing resources and further we describe these syndromes,

including HDL1, HDL2, and HDL4 (SCA17), and also (because of phenotypic overlap) dentatorubral-pallidoluysian atrophy, Friedreich‘s ataxia,

neuroferritinopathy and neuroacanthocytosis.We also bring our proposal for diagnostic process, to diagnose the most frequent syndromes.

However, current worldwide research shows, that major number of patients with HDL phenotype remain without final diagnosis. This suggests

that other genes or gene modifiers may exist, where the mutation can cause the syndrome with clinical features similar to HD.

Keywords: Huntington´s disease, phenocopy, huntingtin, CAG triplet, dentato-rubro-pallido-luysian atrophy, spinocerebellar atrophy, Huntington´s disease like, neuroacanthocytosis, benign hereditary chorea.

Published: July 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kucharík M, Klempíř J, Roth J. Adult-onset huntington disease phenocopies. Neurol. praxi. 2009;10(3):180-183.
Download citation

References

  1. Bhidayasiri R, Perlman SL, Pulst SM, Geschwind DH. Lateonset Friedreich ataxia: phenotypic analysis, magnetic resonance imaging findings, and review of the literature. Arch Neurol 2005 Dec; 62(12): 1865-1869. Go to original source... Go to PubMed...
  2. Burke JR, Ikeuchi T, Koide R, Tsuji S, Yamada M, Pericak-Vance MA, Vance JM. Dentatorubral-pallidoluysian atrophy and Haw River Syndrome. Lancet 1994; 344(8938): 1711-1712. Go to original source... Go to PubMed...
  3. Chinnery PF, Crompton DE, Birchall D, Jackson MJ, Coulthard A, Lomb?s A, Quinn N, Wills A, Fletcher N, Mottershead JP, Cooper P, Kellery M, Bates D, Burn J. Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. Brain 2007; 130(1): 110-119. Go to original source... Go to PubMed...
  4. Curtis AR, Fey C, Morris CM, Bindoff LA, Ince PG, Chinnery PF, Coulthard A, Jackson MJ, Jackson AP, McHale DP, Hay D, Barker WA, Markham AF, Bates D, Curtis A, Burn J. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 2001; 28: 350-354. Go to original source... Go to PubMed...
  5. Crompton DE, Chinnery PF, Fey C, Curtis AR, Morris CM, Kierstan J, Burt A, Young F, Coulthard A, Curtis A, Ince PG, Bates D, Jackson MJ, Burn J. Neuroferritinopathy: a window on the role of iron in neurodegeneration. Blood Cells Mol Dis. 2002 Nov-Dec; 29(3): 522-531. Go to original source... Go to PubMed...
  6. Danek A, Rubio JP, Rampoldi L, Ho M, Dobson-Stone C, Tison F, Symmans WA, Oechsner M, Kalckreuth W, Watt JM, Corbett AJ, Hamdalla HH, Marshall AG, Sutton I, Dotti MT, Malandrini A, Walker RH, Daniels G, Monaco AP. McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol 2001; 50: 755-764. Go to original source... Go to PubMed...
  7. Danek A, Walker RH. Neuroacanthocytosis. Curr Opin Neurol 2005; 18: 386-392. Go to original source... Go to PubMed...
  8. Filla A, De Michele G, Coppola G, Federico A, Vita G, Toscano A, Uncini A, Pisanelli P, Barone P, Scarano V, Perretti A, Santoro L, Monticelli A, Cavalcanti F, Caruso G, Cocozza S. Accuracy of clinical diagnostic criteria for Friedreich's ataxia. Mov Disord. 2000 Nov; 15(6): 1255-1258. Go to original source... Go to PubMed...
  9. Hanna MG, Davis MB, Sweeney MG, Noursadeghi M, Ellis CJ, Elliot P, Wood NW, Marsden CD. Generalized chorea in two patients harboring the Friedreich's ataxia gene trinucleotide repeat expansion. Mov Disord. 1998 Mar; 13(2): 339-340. Go to original source... Go to PubMed...
  10. Hatano T, Okuma Y, Iijima M, Fujishima K, Goto K, Mizuno Y. Cervical dystonia in dentatorubral-pallidoluysian atrophy. Acta Neurol Scand 2003; 108: 287-289. Go to original source... Go to PubMed...
  11. Hewer E, Danek A, Schoser BG, Miranda M, Reichard R, Castiglioni C, Oechsner M, Goebel HH, Heppner FL, Jung HH. McLeod myopathy revisited: more neurogenic and less benign. Brain. 2007 Dec; 130(Pt 12): 3285-3296. Go to original source... Go to PubMed...
  12. Holmes SE, O'Hearn E, Rosenblatt A, Callahan C, Hwang HS, Ingersoll-Ashworth RG, Fleisher A, Stevanin G, Brice A, Potter NT, Ross CA, Margolis RL. A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Nat Genet 2001; 29: 377-378. Go to original source... Go to PubMed...
  13. Kambouris M, Bohlega S, Al-Tahan A, Meyer BF. Localization of the gene for a novel autosomal recessive neurodegenerative Huntington-like disorder to 4p15.3. Am J Hum Genet. 2000 Feb; 66(2): 445-452. Go to original source... Go to PubMed...
  14. Klempír J, Roth J, Zárubová K, Písacka M, Spacková N, Tilley L. The McLeod syndrome without acanthocytes. Parkinsonism Relat Disord. 2008; 14(4): 364-366. Go to original source... Go to PubMed...
  15. Laplanche JL, El Hachimi KH, Durieux I, Thuillet P, Defebvre L, Delasnerie-Laupretre N, Peoc'h K, Foncin JF, Destee A. Prominent psychiatric features and early onset in an inherited prion disease with a new insertional mutation in the prion protein gene. Brain 1999; 122: 2375-2386. Go to original source... Go to PubMed...
  16. Licht D, Lynch D. Juvenile Dentatorubral-Pallidoluysian Atrophy: New Clinical Features. Pediatr Neurol 2002; 26: 51-54. Go to original source... Go to PubMed...
  17. Lin IS, Wu RM, Lee-Chen GJ, Shan DE, Gwinn-Hardy K. The SCA17 phenotype can include features of MSA-C, PSP and cognitive impairment. Parkinsonism Relat Disord. 2007 May; 13(4): 246-249. Go to original source... Go to PubMed...
  18. Margolis RL, Holmes SE, Rosenblatt A, Gourley L, O'Hearn E, Ross CA, Seltzer WK, Walker RH, Ashizawa T, Rasmussen A, Hayden M, Almqvist EW, Harris J, Fahn S, MacDonald ME, Mysore J, Shimohata T, Tsuji S, Potter N, Nakaso K, Adachi Y, Nakashima K, Bird T, Krause A, Greenstein P. Huntington's Disease-like 2 (HDL2) in North America and Japan. Ann Neurol. 2004 Nov; 56 (5): 670-674. Go to original source... Go to PubMed...
  19. Mariotti C, Alpini D, Fancellu R, Soliveri P, Grisoli M, Ravaglia S, Lovati C, Fetoni V, Giaccone G, Castucci A, Taroni F, Gellera C, Di Donato S. Spinocerebellar ataxia type 17(SCA17): oculomotor phenotype and clinical characterization of 15 Italian patients. J Neurol. 2007 Nov; 254(11): 1538-1546. Go to original source... Go to PubMed...
  20. Mead S, Poulter M, Beck J, Webb TE, Campbell TA, Linehan JM, Desbruslais M, Joiner S, Wadsworth JD, King A, Lantos P, Collinge J. Inherited prion disease with six octapeptide repeat insertional mutation-molecular analysis of phenotypic heterogeneity. Brain 2006; 129(Part 9): 2297-2317. Go to original source... Go to PubMed...
  21. Moore RC, Xiang F, Monaghan J, Han D, Zhang Z, Edström L, Anvret M, Prusiner SB. Huntington disease phenocopy is a familial prion disease. Am J Hum Genet 2001; 69: 1385-1388. Go to original source... Go to PubMed...
  22. Peppard RF, Lu CS, Chu NS, Teal P, Martin WR, Calne DB. Parkinsonism with neuroacanthocytosis. Can J Neurol Sci. 1990 Aug; 17(3): 298-301. Go to original source... Go to PubMed...
  23. Rubio JP, Danek A, Stone C, Chalmers R, Wood N, Verellen C, Ferrer X, Malandrini A, Fabrizi GM, Manfredi M, Vance J, Pericak-Vance M, Brown R, Rudolf G, Picard F, Alonso E, Brin M, Németh AH, Farrall M, Monaco AP. Chorea-acanthocytosis: genetic linkage to chromosome 9q21. Am J Hum Genet 1997; 61: 899-908. Go to original source... Go to PubMed...
  24. Santos C, Wanderley H, Vedolin L, Pena SD, Jardim L, Sequeiros J. Huntington disease-like 2: the first patient with apparent European ancestry. Clin Genet. 2008 May; 73(5): 480-485. Go to original source... Go to PubMed...
  25. Schneider SA, van de Warrenburg BP, Hughes TD, Davis M, Sweeney M, Wood N, Quinn NP, Bhatia KP. Phenotypic homogeneity of the Huntington disease-like presentation in a SCA17 family. Neurology 2006; 67: 1701-1703. Go to original source... Go to PubMed...
  26. Tsuji S. Dentatorubral-pallidoluysian atrophy. Clinical features and molecular genetics. Adv Neurol 1999; 79: 399-409.
  27. Walker RH, Rasmussen A, Rudnicki D, Holme SE, Alonso E, Matsuura T, Ashizawa T, Davidoff-Feldman B, Margolis RL. Huntington's disease-like 2 can present as chorea-acanthocytosis. Neurology 2003; 61: 1002-1004. Go to original source... Go to PubMed...
  28. Wild EJ, Tabrizi SJ. Huntington's disease phenocopy syndromes. Curr Opin Neurol 2007 Dec; 20(6): 681-687. Go to original source... Go to PubMed...
  29. Wild EJ, Mudanohwo EE, Sweeney MG, Schneider SA, Beck J, Bhatia KP, Rossor MN, Davis MB, Tabrizi SJ. Huntington's disease phenocopies are clinically and genetically heterogeneous Mov Disord. 2008 Apr 15; 23(5): 716-720. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.